<code id='8BD6A444CA'></code><style id='8BD6A444CA'></style>
    • <acronym id='8BD6A444CA'></acronym>
      <center id='8BD6A444CA'><center id='8BD6A444CA'><tfoot id='8BD6A444CA'></tfoot></center><abbr id='8BD6A444CA'><dir id='8BD6A444CA'><tfoot id='8BD6A444CA'></tfoot><noframes id='8BD6A444CA'>

    • <optgroup id='8BD6A444CA'><strike id='8BD6A444CA'><sup id='8BD6A444CA'></sup></strike><code id='8BD6A444CA'></code></optgroup>
        1. <b id='8BD6A444CA'><label id='8BD6A444CA'><select id='8BD6A444CA'><dt id='8BD6A444CA'><span id='8BD6A444CA'></span></dt></select></label></b><u id='8BD6A444CA'></u>
          <i id='8BD6A444CA'><strike id='8BD6A444CA'><tt id='8BD6A444CA'><pre id='8BD6A444CA'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:632
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Cord blood banking comes at a high cost to babies
          Cord blood banking comes at a high cost to babies

          Ifhersocialmediaaccountsareanyindication,model,cookbookauthor,televisionpersonality,andentrepreneurC

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Letters to First Opinion on caregivers, digital health, and more

          MollyFergusonforSTATToencouragerobust,good-faithdiscussionaboutissuesraisedinFirstOpinion,STATpublis